A microbial-derived solution targeting AI-2 quorum sensing to prevent dental plaque in companion animals. This non-antibiotic approach inhibits biofilm formation, preserving beneficial microbes and promoting oral health without causing dysbiosis.
This innovative solution involves a microbial-derived product that inhibits AI-2 mediated quorum sensing, a key driver of dental plaque formation in companion animals. By targeting microbial communication rather than viability, this approach prevents biofilm development without disrupting beneficial oral bacteria, reducing the risk of dysbiosis and promoting long-term oral health in pets.
The technology is currently at TRL 4, indicating that it has been validated in lab conditions. Further development will include more comprehensive testing and formulation refinement prior to commercial application.
UMass Amherst is a comprehensive public research university and the flagship campus of the University of Massachusetts system, with a large student body and a robust research enterprise. Industry engagement centers on company access to an integrated network of shared core facilities and co-located labs, with options for on‑site residency in an adjacent research and technology park. A dedicated industry partnerships team streamlines sponsored research, material transfer, and confidentiality agreements and connects partners to faculty expertise, prototyping, and pilot‑scale testing. Research is supported by competitive federal funding from agencies such as the National Science Foundation, National Institutes of Health, the U.S. Department of Energy, the Department of Defense, and the U.S. Department of Agriculture. A technology transfer office advises on IP strategy, manages licensing, and supports new venture formation.